Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients newly diagnosed or previously diagnosed with gout based on clinical features and raised serum uric acid levels are included. Patients in the age group of thirty to seventy years are included. Both male and female patients are included. Patients experiencing acute gouty arthritis or recurrent gout attacks are included. Patients willing to participate and provide informed consent are included.
Exclusion criteria
Exclusion criteria: Patients with secondary gout due to renal failure, leukemia, or other systemic diseases are excluded. Patients with severe renal impairment, hepatic dysfunction, or uncontrolled diabetes mellitus are excluded. Patients with a history of joint deformities due to advanced chronic gout are excluded. Patients receiving long term urate lowering therapy such as allopurinol or febuxostat, or corticosteroids are excluded. Pregnant and lactating women are excluded. Patients who are unwilling or unable to comply with study requirements are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study is expected to demonstrate a significant reduction in gout symptoms such as joint pain, swelling, and stiffness through individualized homoeopathic treatment using Colchicum, Ledum palustre, and Lycopodium. Improvement in patients quality of life, while also validating the use of standardized homoeopathic assessment tools for monitoring clinical progress . These outcomes will support evidence-based homoeopathic practice, promote the clinical utility of assessment tools, and offer a safe, holistic alternative to conventional treatment. The findings may also encourage further research homoeopathic management of gout and related musculoskeletal conditions.Timepoint: 1 years | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
L.R Shah Homoeopathy college